Fludara and Crestor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fludara (fludarabine phosphate) and Crestor (rosuvastatin calcium). Common drug interactions include full blood count decreased among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Fludara and Crestor. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.

On Jul, 19, 2026

47 people who take Fludara and Crestor together, and have interactions are studied.

What are the common drug interactions of Fludara and Crestor, by gender? *:

female:

Full blood count decreased
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hypervolaemia (abnormally increased volume of blood)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Necrosis (the death of body tissue)
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Wound
Nausea (feeling of having an urge to vomit)

male:

Pyrexia (fever)
Nausea (feeling of having an urge to vomit)
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Anaemia (lack of blood)
Back pain
Platelet count decreased
Urinary tract infection
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

What are the common drug interactions of Fludara and Crestor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Chest pain
Haemoglobin decreased
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
Vomiting
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Bacterial infection
Blood amylase increased

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain upper
Cardiac failure acute
Cardiac failure congestive
Drug ineffective
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)
Weight decreased

50-59:

Wound
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Cytomegalovirus test positive
Multi-organ failure (multisystem organ failure)
Renal neoplasm (kidney tumour)
Venoocclusive disease (small veins in the liver are obstructed)
Malignant neoplasm progression (cancer tumour came back)
Cataract (clouding of the lens inside the eye)
Full blood count decreased
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)

60+:

Pyrexia (fever)
Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Back pain
Platelet count decreased
Urinary tract infection
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Fatigue (feeling of tiredness)
Rash

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 22 people, 46.81%
Type 2 Diabetes: 7 people, 14.89%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 12.77%
Bone Marrow Conditioning Regimen: 6 people, 12.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 10.64%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 4 people, 8.51%
Infection: 4 people, 8.51%
High Blood Pressure: 4 people, 8.51%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 8.51%
Neoplasm Malignant (cancer tumour): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Fludara and Crestor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously